Vivos Therapeutics, Inc. Stock
Equities
VVOS
US92859E2072
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.09 USD | +7.18% | -0.48% | -83.20% |
May. 14 | Transcript : Vivos Therapeutics, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Vivos Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 14.9M | Sales 2025 * | 18.41M | Capitalization | 6.74M |
---|---|---|---|---|---|
Net income 2024 * | -12M | Net income 2025 * | -10M | EV / Sales 2024 * | 0.45 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.37 x |
P/E ratio 2024 * |
-0.5
x | P/E ratio 2025 * |
-0.92
x | Employees | 119 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.75% |
Latest transcript on Vivos Therapeutics, Inc.
1 day | +7.18% | ||
1 week | -0.48% | ||
1 month | -17.39% | ||
3 months | -64.03% | ||
6 months | -91.47% | ||
Current year | -83.20% |
Managers | Title | Age | Since |
---|---|---|---|
Todd Huntsman
FOU | Founder | - | 16-07-06 |
RaeAnn Byrnes
FOU | Founder | - | 16-07-06 |
Susan McCullough
FOU | Founder | - | 16-07-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Leonard Sokolow
BRD | Director/Board Member | 67 | 20-05-31 |
Mark Lindsay
BRD | Director/Board Member | 61 | 20-05-31 |
Anja Krammer
BRD | Director/Board Member | 56 | 20-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 2.09 | +7.18% | 18,668 |
24-05-30 | 1.95 | -0.51% | 35,490 |
24-05-29 | 1.96 | -5.31% | 46,319 |
24-05-28 | 2.07 | -1.43% | 122,558 |
24-05-24 | 2.1 | +0.48% | 19,303 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-83.20% | 6.74M | |
+75.69% | 12.57B | |
-24.68% | 7.34B | |
+6.22% | 6.61B | |
+12.58% | 5.39B | |
-16.63% | 4.84B | |
+26.90% | 4.53B | |
-21.14% | 3.91B | |
-22.99% | 2.91B | |
+47.42% | 2.37B |
- Stock Market
- Equities
- VVOS Stock